UNSPSC 51452403: Flubendazole

This classification denotes an antihelminthic agent with the molecular formula C16H12FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8M46911LR, chemically known as 2-benzimidazolecarbamic acid, 5-(p-fluorobenzoyl)-, methyl ester but generally known as flubendazole, which bears US NIH Compound Identifier 35802. European Medicines Agency schedules Flubendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07666MIG.

UNSPSC 51452403 Flubendazole is a Commodity code that nominally describes a specific anthelminthic pharmaceutical active ingredient, but recent state and local opportunities show little activity directly tied to flubendazole procurement. The two most recent records in the system reflect pharmaceutical supply chain activity more broadly — a completed piggyback award through the Illinois Department of Public Health for antimicrobial tablets (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and a Seminole County, Florida competitive bid for naloxone and drug deactivation systems. Neither opportunity involves flubendazole directly, suggesting the code may be tagged inconsistently or that state and local jurisdictions pursue flubendazole through broader pharmaceutical supply contracts rather than as a standalone line item.

Activity is geographically scattered and limited. The Illinois Department of Public Health's completed award to Chartwell Rx LLC on August 28, 2026 for $2,999,999.11 over a 12-month term with two renewal years demonstrates use of cooperative purchasing vehicles (MMCAP Infuse consortium) to aggregate pharmaceutical inventories, but the specific products awarded do not match the code. The Seminole County, Florida IFB for naloxone and drug deactivation systems (posted June 30, 2026, due July 26, 2026) shows county-level health procurement activity but again addresses a different therapeutic class. With no open solicitations or awarded opportunities explicitly tagged to flubendazole, the code shows little current state and local procurement relevance and warrants monitoring for future activity rather than pursuit.